Inflammatory Bowel Disease

The connection between disordered eating and GI seems like an easy one to make.

Serological responses from patients with inflammatory bowel disease on biologic therapies had 100% seropositivity after two doses of the COVID-19 mRNA vaccinations, according to a study published in Gastroenterology.

Anti-COVID-19 antibody responses are attenuated in patients who receive infliximab for inflammatory bowel disease, according to a speaker at the 2021 Interdisciplinary Autoimmune Summit.

Simultaneous use of biologic agents in combination or with Xeljanz may be a viable treatment option for highly selected, refractory patients with inflammatory bowel disease, according to study results.

Researchers found that specific foods and nutrients correlated with species known to have mucosal protection and anti-inflammatory effects, according to data published in Gut.

These reports include new research on the impact of greenspace exposure, gluten intake and yeast commonly found in cheese.

Healio Gastroenterology presents the following reports on the most recent research on COVID-19 is gastrointestinal conditions.

Dietary gluten intake was not associated with risk for Crohn’s disease or ulcerative colitis, according to study results.

Researchers from Cleveland Clinic found an infection that prevents healing in patients with Crohn’s disease, according to study results published in Science.

Remicade use in inflammatory bowel disease was linked to attenuated serological response to SARs-CoV-2, which were further blunted by immunomodulators used as concomitant therapy, according to a study published in Gut.